Dr. Bradley S. Kurgis, DO

Dr. Kurgis practices at Templeton Endoscopy Center in Templeton, California.

Dr. Kurgis' NPI, 1770529620, was assigned on June 21, 2006. Dr. Kurgis graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 1987. Dr. Kurgis holds California license 20A5517.

Dr. Kurgis' primary practice is Templeton Endoscopy Center, at 1320 Las Tablas Ste A, Templeton, CA 93465. The practice phone is (805) 434-9950.

Dr. Kurgis' primary practice is Templeton Endoscopy Center in Templeton, California. The medical group on file is Dr. Bradley Kurgis Dermatology. Dmand AI also links Dr. Kurgis to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kurgis practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Kurgis' primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Kurgis is board certified in 1988 - 2026 by the CA State License. Dr. Kurgis is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Kurgis treats.

CMS data shows 9,112 Medicare services from Dr. Kurgis across 28 procedure codes in 2024, for 1,324 Medicare patients. Medicare paid $530,403 for them. Every service was in an office.

CMS counts 1,324 Medicare patients who saw Dr. Kurgis in 2024. The largest group is 65 to 74, with 681 patients. 73% of them have high cholesterol, and 64% have high blood pressure. 12% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kurgis' median patient age at 69, with 52% women.

In 2024, Dr. Kurgis wrote 1,166 Medicare Part D claims for 493 patients. 93% of them were for generic drugs. CMS names the drug for 1,046 of them, across 27 drugs with 11 or more claims each, at $331,700 in total drug cost. In 2023, CMS named 918 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kurgis for performance year 2024, reported individually. Dr. Kurgis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 360 procedures of melanoma (skin cancer) excision by Dr. Kurgis, more than 99% of the clinicians it reports for that procedure.

CMS Open Payments shows 384 general payments to Dr. Kurgis from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $1,465.

Dr. Kurgis graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 1987.

Dr. Kurgis is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.